Outcomes Following Neoadjuvant or Adjuvant Chemotherapy for cT2-4N0-1 Non-Small Cell Lung Cancer: A Propensity-Matched Analysis

OBJECTIVE: Comparative survival between neoadjuvant chemotherapy (NC) and adjuvant chemotherapy (AC) for patients with cT2-4N0-1M0 non-small cell lung cancer (NSCLC) has not been extensively studied. METHODS: Patients with cT2-4N0-1M0 NSCLC who received platinum-based chemotherapy were retrospective...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Cardiovasc Surg
Asıl Yazarlar: Brandt, Whitney S., Yan, Wanpu, Zhou, Jian, Tan, Kay See, Montecalvo, Joseph, Park, Bernard J., Adusumilli, Prasad S., Huang, James, Bott, Matthew J., Rusch, Valerie W., Molena, Daniela, Travis, William D., Kris, Mark G., Chaft, Jamie E., Jones, David R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344258/
https://ncbi.nlm.nih.gov/pubmed/30415902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.09.098
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller